400 related articles for article (PubMed ID: 35173552)
1. CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction.
Zhang N; Ma Q; You Y; Xia X; Xie C; Huang Y; Wang Z; Ye F; Yu Z; Xie X
Int J Biol Sci; 2022; 18(3):1271-1287. PubMed ID: 35173552
[No Abstract] [Full Text] [Related]
2. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
3. Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis.
Glezeva N; Voon V; Watson C; Horgan S; McDonald K; Ledwidge M; Baugh J
J Card Fail; 2015 Feb; 21(2):167-77. PubMed ID: 25459685
[TBL] [Abstract][Full Text] [Related]
4. Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure.
Smart CD; Fehrenbach DJ; Wassenaar JW; Agrawal V; Fortune NL; Dixon DD; Cottam MA; Hasty AH; Hemnes AR; Doran AC; Gupta DK; Madhur MS
Cardiovasc Res; 2023 Oct; 119(13):2312-2328. PubMed ID: 37314125
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction.
Tamaki S; Mano T; Sakata Y; Ohtani T; Takeda Y; Kamimura D; Omori Y; Tsukamoto Y; Ikeya Y; Kawai M; Kumanogoh A; Hagihara K; Ishii R; Higashimori M; Kaneko M; Hasuwa H; Miwa T; Yamamoto K; Komuro I
PLoS One; 2013; 8(7):e68893. PubMed ID: 23894370
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction.
Zhang L; Chen J; Yan L; He Q; Xie H; Chen M
Front Pharmacol; 2021; 12():646240. PubMed ID: 34177571
[No Abstract] [Full Text] [Related]
7. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
[TBL] [Abstract][Full Text] [Related]
8. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
9. Cardiac sympathetic overdrive, M2 macrophage activation and fibroblast heterogeneity are associated with cardiac remodeling in a chronic pressure overload rat model of HFpEF.
Sun F; Yuan L; Wang Z; Cui X; Lv N; Zhang T; Zhang Y; Cai J
Front Pharmacol; 2024; 15():1364758. PubMed ID: 38860171
[TBL] [Abstract][Full Text] [Related]
10. Preload dependence in an animal model of mild heart failure with preserved ejection fraction (HFpEF).
Jacobsen JCB; Schubert IH; Larsen K; Terzic D; Thisted L; Thomsen MB
Acta Physiol (Oxf); 2024 Mar; 240(3):e14099. PubMed ID: 38230889
[TBL] [Abstract][Full Text] [Related]
11. Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.
Glezeva N; Baugh JA
Heart Fail Rev; 2014 Sep; 19(5):681-94. PubMed ID: 24005868
[TBL] [Abstract][Full Text] [Related]
12. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
[TBL] [Abstract][Full Text] [Related]
13. Advances in extracardiac mechanisms for heart failure with preserved ejection fraction.
Wang S; Xiao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1733-1739. PubMed ID: 36748385
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
15. Knockout of MD1 contributes to sympathetic hyperactivity and exacerbates ventricular arrhythmias following heart failure with preserved ejection fraction via NLRP3 inflammasome activation.
Yang HJ; Kong B; Shuai W; Zhang JJ; Huang H
Exp Physiol; 2020 Jun; 105(6):966-978. PubMed ID: 32240565
[TBL] [Abstract][Full Text] [Related]
16. TAX1BP1 downregulation by STAT3 in cardiac fibroblasts contributes to diabetes-induced heart failure with preserved ejection fraction.
Zuo GF; Wang LG; Huang L; Ren YF; Ge Z; Hu ZY; Zhang JJ; Chen SL
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166979. PubMed ID: 38065272
[TBL] [Abstract][Full Text] [Related]
17. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
18. Unmasking of oestrogen-dependent changes in left ventricular structure and function in aged female rats: a potential model for pre-heart failure with preserved ejection fraction.
Bustamante M; Garate-Carrillo A; R Ito B; Garcia R; Carson N; Ceballos G; Ramirez-Sanchez I; Omens J; Villarreal F
J Physiol; 2019 Apr; 597(7):1805-1817. PubMed ID: 30681142
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction.
Kanashiro-Takeuchi RM; Takeuchi LM; Dulce RA; Kazmierczak K; Balkan W; Cai R; Sha W; Schally AV; Hare JM
Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H739-H750. PubMed ID: 36897749
[TBL] [Abstract][Full Text] [Related]
20. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
